ocular cancer | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

99,204 results for “ocular cancer”

Trials

View all 80619 →

Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

100 participants · First posted Dec 10, 2024

Ocular Complications From Cancer Therapy - Patient Registry and Biobank

150 participants · First posted Mar 13, 2025

Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers

25 participants · First posted Apr 4, 2023

Drugs

View all 2334 →

Cancers of ocular surface program

ShK-Ocular

Ocular Extractives

Organizations

View all 1109 →

Ocular Therapeutix

United States

Ocular Therapeutix, Inc.

United States

Refocus Group, Inc.

United States

News

View all 15142 →

IDEAYA Biosciences Completes Enrollment in Pivotal Trial for Darovasertib Combination in Metastatic Uveal Melanoma

Pig Semen-Derived Eye Drops Show Promise for Retinoblastoma Treatment in Preclinical Studies

Sanofi Prepares Enhanced Takeover Bid for Ocular Therapeutix Following Rejected $16 Per Share Offer

Page 1 of 9921